Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
Takeda posts results for TAK-881 vs HYQVIA pharmacokinetic study in PIDD patientsSep 30Trial updateTakeda Pharmaceutical Co Ltd
Pfizer posts MET097 obesity results; registers new Phase 3 obesity and dermatitis trialsAug 28Weekly roundup, 6 itemsberobenatidePF-08154225